ArticleJCO precision oncology2019

Predicting Expected Absolute Chemotherapy Treatment Benefit in Women With Early-Stage Breast Cancer Using EndoPredict, an Integrated 12-Gene Clinicomolecular Assay.

Hatem Soliman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.